The Defiance Daily Target 2X Long RKLB ETF (RKLX) provides leveraged 200% daily exposure to Rocket Lab (RKLB) shares, driven by the company's growth in medium-lift rockets, increasing launch frequency, and an upcoming acquisition of Iridium. This ETF is recommended for short-term traders due to its high volatility, compounding risk, and a beta of 2.80 relative to RKLB. While liquidity is strong, investors should consider trading costs from a 0.28% bid/ask spread and a 1.29% expense ratio. Overall, RKLX is positioned as a tool for tactical exposure rather than a long-term investment.
Rocket Lab Corporation received a Buy upgrade as its shares reclaimed the key $60 level, reflecting strong investor confidence despite market volatility. The company boasts a $3.6 billion backlog, more than doubling year over year, with the first 16 ...
Rocket Lab plans to launch its 100th Electron rocket on November 14, 2026, from New Zealand, marking the fastest achievement of 100 launches by any commercial rocket. The mission, named "The Mountain God Rises," will deploy an Earth-imaging satellite...
Rocket Lab's stock fell 9% after its Q3 report showed record backlog but a wider-than-expected loss, driven by one-time costs and delayed Neutron rocket launch. AST SpaceMobile dropped 6% following a price target cut by Bank of America due to slower ...
Rocket Lab's stock fell nearly 50% over six months due to delays in its Neutron rocket launch now pushed to 2027, dilution from equity raises, and margin pressure. Despite these setbacks, the company reported a record $3.57 billion backlog and strong...
Rocket Lab is gaining momentum in the private space industry with a diversified business model and strong leadership. Its backlog grew from $2.36 billion in Q2 to $3.5 billion in Q3, reflecting high confidence from customers. However, risks remain fr...
